36 filings
8-K
IMPLQ
Impel Pharmaceuticals Inc
12 Mar 24
Amendments to Articles of Incorporation or Bylaws
8:43am
8-K
IMPLQ
Impel Pharmaceuticals Inc
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
IMPLQ
Impel Pharmaceuticals Inc
2 Jan 24
Other Events
4:23pm
8-K
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
8-K
IMPLQ
Impel Pharmaceuticals Inc
18 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:31am
8-K
ad8bsp7xww
4 Dec 23
Departure of Directors or Certain Officers
6:05am
8-K
nq15cp0g
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
pdmv907 ovdhowb
2 Nov 23
Departure of Directors or Certain Officers
5:20pm
8-K
xlwf4g3
16 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
gnw7 bzucn
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
7acs y2edd1g
18 Sep 23
Regulation FD Disclosure
9:53pm
8-K
hlfehz rxxw
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
v6o2qegth3r1vf
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
2fuk6wopc4a0ek8qu5c
16 Jun 23
Submission of Matters to a Vote of Security Holders
9:18am
8-K
gf2i6u9 lhatb1q
12 May 23
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
8:03am
8-K
kod qwot8
10 May 23
Departure of Directors or Certain Officers
8:10am
8-K
huxaedwj jxehdb
17 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
1vc71
12 Apr 23
Departure of Directors or Certain Officers
4:06pm
8-K
vcu1vu yw00
24 Mar 23
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:21am
8-K
xh8q9v atpii19esouns
3 Mar 23
Departure of Directors or Certain Officers
4:06pm